On March 24, 2026, IDEXX Laboratories, Inc. disclosed in an 8-K filing that Nimrata Hunt, PhD, the Executive Vice President of Global Strategy and Commercial, will be leaving the company effective April 13, 2026. This decision was mutually agreed upon, and Dr. Hunt will continue to provide advisory services until July 13, 2026. The separation agreement includes a substantial financial package for Dr. Hunt, totaling approximately $2.286 million, which encompasses salary continuation, bonuses, and other benefits. The agreement also stipulates that Dr. Hunt's stock options and other equity awards will cease vesting upon her final employment date. This leadership change may impact the company's strategic direction, particularly in its global strategy and commercial operations, as Dr. Hunt has been a key figure in these areas. The company has indicated that her position is being eliminated, categorizing the separation as a termination without cause, which may have implications for the company's governance and operational execution moving forward.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.